EligibleTrials

F 18 T807 Tau PET Imaging of Alzheimer's Disease

Recruiting · NCT02414347 · Observational (researchers observe without assigning treatment) · Lead sponsor: Tammie L. S. Benzinger, MD, PhD

View the official record on ClinicalTrials.gov →
Alzheimer's disease

Interventions studied

F 18 T807

What this trial is about

A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.